Fluorescent nanodiamond tracking reveals intraneuronal transport abnormalities induced by brain-disease-related genetic risk factors

Tracking fluorescent nanodiamond inside branches of neurons is a sensitive method to measure the changes in intraneuronal transport due to genetic risk factors associated with brain diseases. Brain diseases such as autism and Alzheimer's disease (each inflicting >1% of the world population)...

Full description

Saved in:
Bibliographic Details
Published in:Nature nanotechnology Vol. 12; no. 4; pp. 322 - 328
Main Authors: Haziza, Simon, Mohan, Nitin, Loe-Mie, Yann, Lepagnol-Bestel, Aude-Marie, Massou, Sophie, Adam, Marie-Pierre, Le, Xuan Loc, Viard, Julia, Plancon, Christine, Daudin, Rachel, Koebel, Pascale, Dorard, Emilie, Rose, Christiane, Hsieh, Feng-Jen, Wu, Chih-Che, Potier, Brigitte, Herault, Yann, Sala, Carlo, Corvin, Aiden, Allinquant, Bernadette, Chang, Huan-Cheng, Treussart, François, Simonneau, Michel
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 01-04-2017
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Tracking fluorescent nanodiamond inside branches of neurons is a sensitive method to measure the changes in intraneuronal transport due to genetic risk factors associated with brain diseases. Brain diseases such as autism and Alzheimer's disease (each inflicting >1% of the world population) involve a large network of genes displaying subtle changes in their expression 1 . Abnormalities in intraneuronal transport have been linked to genetic risk factors found in patients 2 , 3 , suggesting the relevance of measuring this key biological process. However, current techniques are not sensitive enough to detect minor abnormalities. Here we report a sensitive method to measure the changes in intraneuronal transport induced by brain-disease-related genetic risk factors using fluorescent nanodiamonds (FNDs). We show that the high brightness, photostability and absence of cytotoxicity 4 allow FNDs to be tracked inside the branches of dissociated neurons with a spatial resolution of 12 nm and a temporal resolution of 50 ms. As proof of principle, we applied the FND tracking assay on two transgenic mouse lines that mimic the slight changes in protein concentration (∼30%) found in the brains of patients. In both cases, we show that the FND assay is sufficiently sensitive to detect these changes.
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1748-3387
1748-3395
DOI:10.1038/nnano.2016.260